Clinical Trial Update: Head-to-Head Comparison of All Botulinum Neurotoxin Type A Products for Glabellar Rhytides [Phase 4]

View source ↗

Summary

Phase 4 trial update comparing all botulinum toxin type A products for treating glabellar rhytides; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glabellar Rhytides

Drugs mentioned

• BOTOX COSMETIC (ONABOTULINUMTOXINA)
• Dysport (abobotulinumtoxinA)
• Jeuveau (prabotulinumtoxinA)
• XEOMIN (INCOBOTULINUMTOXINA)

Snippet

Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | Conditions: Wrinkle | Phase 4 | Status: NOT_YET_RECRUITING